Lifecore Biomedical, Inc. \De\ (LFCR) Cash from Investing Activities (2010 - 2025)

Lifecore Biomedical, Inc. \De\'s Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$2.1 million for Q2 2025.

• In Q2 2025, Cash from Investing Activities rose 22.71% year-over-year to -$2.1 million; the TTM figure through May 2025 stood at -$6.4 million (up 65.13% YoY), while the FY2025 annual figure was -$6.4 million, up 65.13% from the prior year.
• Cash from Investing Activities for Q2 2025 stood at -$2.1 million, down from $1.5 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $65.2 million in Q1 2022, with the low at -$17.5 million in Q2 2022.
• The 5-year median for Cash from Investing Activities is -$3.6 million (2022), against an average of $1.8 million.
• The sharpest annual moves came in 2021 and 2023: Cash from Investing Activities surged 139607.41% in 2021, then sank 2136.28% in 2023.
• Lifecore Biomedical, Inc. \De\'s Cash from Investing Activities stood at -$5.4 million in 2021, then increased by 29.06% to -$3.8 million in 2022, then slipped by 10.73% to -$4.3 million in 2023, then surged by 42.74% to -$2.4 million in 2024, then increased by 14.06% to -$2.1 million in 2025.
• Business Quant data shows LFCR's Cash from Investing Activities at -$2.1 million in Q2 2025, $1.5 million in Q1 2025, and -$2.4 million in Q4 2024.